Treatment for Irritated Keloid Scar
For an irritated keloid scar, start with intralesional triamcinolone acetonide (10-40 mg/mL) combined with 5-fluorouracil, which provides superior symptom control and flattening compared to steroid monotherapy. 1, 2
First-Line Treatment Approach
Intralesional Corticosteroid Therapy
- Triamcinolone acetonide 10-40 mg/mL injected directly into the keloid 1
- For hypertrophic scars and keloids specifically, use the 40 mg/mL concentration 1
- This remains the gold standard first-line treatment with the most consistent evidence 3, 4, 5
Enhanced Combination Therapy
Add intralesional 5-fluorouracil to the corticosteroid injection for superior outcomes compared to steroid alone 4, 2, 5. This combination:
- Provides more reliable flattening and symptom control
- Reduces recurrence rates
- Addresses both inflammation and fibroproliferation 2
Adjunctive Treatments for Symptom Control
For Immediate Irritation Relief
- Topical corticosteroid ointments to reduce local inflammation 3
- Silicone gel sheets applied continuously - these reduce tension, hydrate the scar, and decrease inflammation 3, 4, 6
- Consider corticosteroid-infused tapes or plasters for combined anti-inflammatory and occlusive effects 3
If Pruritus or Pain is Prominent
- OnabotulinumtoxinA injection appears superior to both fluorouracil and corticosteroid injections alone for treating symptomatic keloids 3, 2
- Particularly effective when tension or contracture contributes to symptoms 2
Second-Line Options for Refractory Cases
Intralesional Cryotherapy
Liquid nitrogen injected directly into the scar (not just surface application) is highly beneficial, especially for non-auricular keloids 3, 7
- The combination of intralesional triamcinolone plus intralesional cryotherapy shows the most promising results for non-auricular keloids 7
- More effective than surface cryotherapy alone 8
Additional Intralesional Agents
If the keloid remains symptomatic despite corticosteroid + 5-FU:
- Bleomycin intralesional injection 4, 6
- Verapamil intralesional injection 4, 6
- Note: These show mixed results but can be considered as adjuncts 4
Advanced Modalities for Resistant Keloids
Laser Therapy
- Fractional CO2 laser for thickness and texture improvement 2
- Can be combined with intralesional corticosteroids or used with topical steroids under occlusion to improve drug penetration 4
- Laser-assisted drug delivery enhances treatment efficacy 3
Radiation Therapy
For recalcitrant lesions after other treatments have failed:
- Superficial beta-brachytherapy with strontium-90 as consolidation after response to intralesional therapy 2
- External beam radiation or brachytherapy for selected thin keloids 2
- Considered safe with low cancer risk 3
Critical Treatment Principles
Avoid These Common Pitfalls
- Do not use corticosteroid injections on eyelids, lips, nose, or ears - risk of local atrophy and complications 1, 8
- Avoid overdosing local corticosteroids - can result in atrophy, pigmentary changes, and telangiectasias 1
- Do not treat solely with physical methods if there's evidence of potential dissemination 8
- In darker skin types, use conservative parameters for all procedures due to higher risk of pigmentary adverse effects 2
Important Monitoring
- Watch for local corticosteroid adverse effects: atrophy, pigmentary changes, telangiectasias, hypertrichosis 1
- Sterile abscess formation can occur with intralesional injections 1
- Repeated injections can suppress the hypothalamic-pituitary-adrenal axis 1
Treatment Duration and Follow-up
- Keloids have notoriously high recurrence rates 9, 5
- Follow-up is essential - this is not a one-time treatment 9
- Multiple treatment sessions are typically required 4, 10
- Combination therapies produce superior outcomes compared to monotherapy 10, 5
Special Considerations
For patients with history of keloid formation: The outcome is uncertain with any skin trauma 11. Prevention counseling is critical for these patients to avoid elective procedures that puncture the skin 11.
Sole treatments and inadequate therapy are major risk factors for recurrence 10. This is why the combination approach (corticosteroid + 5-FU) is emphasized over monotherapy.
The evidence consistently shows that multimodal strategies targeting both inflammation and fibroproliferation yield better results than single-agent therapy 4, 10, 5. The irritation itself indicates active inflammation, making anti-inflammatory treatment with corticosteroids the logical starting point, enhanced by the anti-fibrotic effects of 5-FU.